This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for CCM2? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the CCM2 IHC GuideFacts about Cerebral cavernous malformations 2 protein.
May serve as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a significant role in the modulation of MAP3K3- dependent p38 activation induced by hyperosmotic shock (By similarity).
| Human | |
|---|---|
| Gene Name: | CCM2 |
| Uniprot: | Q9BSQ5 |
| Entrez: | 83605 |

| Belongs to: |
|---|
| CCM2 family |

C7orf22OSM; cerebral cavernous malformation 2; Cerebral cavernous malformations 2 protein; chromosome 7 open reading frame 22; malcavernin; MGC4067; MGC4607; MGC74868
Mass (kDA):
48.837 kDA

| Human | |
|---|---|
| Location: | 7p13 |
| Sequence: | 7; NC_000007.14 (44999746..45076470) |
Cytoplasm.





PMID: 14624391 by Liquori C.L., et al. Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.
PMID: 20489202 by Li X., et al. Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity.